Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
CESC | rs525617 | chr17:72890457 | G/C | 2.16E-5 | 299 | 15.33 | 27.9 | 21.2 | KM Plot |
CESC | rs529286 | chr17:72884294 | T/C | 1.37E-5 | 292 | 16.87 | 28.3 | 21.2 | KM Plot |
CESC | rs538216 | chr17:72888126 | T/G | 2.16E-5 | 299 | 15.33 | 27.9 | 21.2 | KM Plot |
CESC | rs540555 | chr11:125486848 | T/C | 8.1E-6 | 295 | 11.6 | 25.33 | 21.33 | KM Plot |
CESC | rs540723 | chr11:125489621 | A/G | 8.1E-6 | 295 | 11.6 | 25.33 | 21.33 | KM Plot |
CESC | rs540725 | chr17:72888345 | A/G | 1.62E-5 | 299 | 16.87 | 27.77 | 21.2 | KM Plot |
CESC | rs543389 | chr11:125464841 | A/G | 4.75E-6 | 287 | 11.67 | 27.8 | 21.13 | KM Plot |
CESC | rs548181 | chr11:125461709 | A/G | 4.62E-6 | 291 | 11.67 | 27.5 | 21.1 | KM Plot |
CESC | rs550347 | chr17:72890837 | C/T | 1.85E-5 | 295 | 16.87 | 27.63 | 21.2 | KM Plot |
CESC | rs552136 | chr17:72891023 | G/A | 2.46E-5 | 295 | 15.33 | 27.77 | 21.2 | KM Plot |
CESC | rs554047 | chr11:125518245 | T/A | 1.13E-5 | 293 | 11.6 | 26.5 | 21.13 | KM Plot |
CESC | rs55704863 | chr3:129165000 | A/G | 4.75E-5 | 295 | 21.47 | 20.95 | 14.73 | KM Plot |
CESC | rs55708833 | chr3:129239622 | G/T | 4.71E-5 | 295 | 21.73 | 20.63 | 14.73 | KM Plot |
CESC | rs55728317 | chr3:129220891 | G/A | 4.8E-5 | 295 | 21.47 | 20.63 | 14.73 | KM Plot |
CESC | rs55737640 | chr4:84360605 | C/A | 0 | 289 | 21.15 | 29.48 | 1.73 | KM Plot |